Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis.

Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R, Barohn RJ, Saperstein DS, Briemberg HR, Ericsson M, Park P, Amato AA.

Ann Neurol. 2005 May;57(5):664-78.

PMID:
15852401
2.

Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.

de Padilla CM, Reed AM.

Curr Opin Rheumatol. 2008 Nov;20(6):669-74. doi: 10.1097/BOR.0b013e3283157538. Review.

PMID:
18946326
3.

Inflammatory myopathies: evaluation and management.

Greenberg SA.

Semin Neurol. 2008 Apr;28(2):241-9. doi: 10.1055/s-2008-1062267. Review.

PMID:
18351525
4.

Pathogenesis of myositis in children.

Griffin TA, Reed AM.

Curr Opin Rheumatol. 2007 Sep;19(5):487-91. Review.

PMID:
17762616
5.

A gene expression approach to study perturbed pathways in myositis.

Greenberg SA.

Curr Opin Rheumatol. 2007 Nov;19(6):536-41. Review.

PMID:
17917532
6.

Role of cytokines and chemokines in idiopathic inflammatory myopathies.

De Paepe B, Creus KK, De Bleecker JL.

Curr Opin Rheumatol. 2009 Nov;21(6):610-6. doi: 10.1097/BOR.0b013e3283317b31. Review.

PMID:
19726994
7.

Cytokines in juvenile dermatomyositis pathophysiology: potential and challenge.

Uzel G, Pachman LM.

Curr Opin Rheumatol. 2003 Nov;15(6):691-7. Review.

PMID:
14569197
8.

[Dermatomyositis].

Stoltenburg-Didinger G, Genth E.

Z Rheumatol. 2009 Jun;68(4):287-94. doi: 10.1007/s00393-008-0398-y. Review. German.

PMID:
19330338
9.

Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.

Gherardi RK.

Presse Med. 2011 Apr;40(4 Pt 2):e209-18. doi: 10.1016/j.lpm.2010.12.013. Review.

PMID:
21376512
10.

Molecular immunology and genetics of inflammatory muscle diseases.

Dalakas MC.

Arch Neurol. 1998 Dec;55(12):1509-12. Review.

PMID:
9865793
11.

Immune effector mechanisms in inflammatory myopathies.

Engel AG, Arahata K, Emslie-Smith A.

Res Publ Assoc Res Nerv Ment Dis. 1990;68:141-57. Review.

PMID:
2158132
12.

Inflammatory muscle diseases: a critical review on pathogenesis and therapies.

Dalakas MC.

Curr Opin Pharmacol. 2010 Jun;10(3):346-52. doi: 10.1016/j.coph.2010.03.001. Review.

PMID:
20409756
13.

Immunopathogenesis of juvenile dermatomyositis.

Khanna S, Reed AM.

Muscle Nerve. 2010 May;41(5):581-92. doi: 10.1002/mus.21669. Review.

PMID:
20405498
14.

New developments in the role of cytokines and chemokines in inflammatory myopathies.

Lundberg IE, Nyberg P.

Curr Opin Rheumatol. 1998 Nov;10(6):521-9. Review.

PMID:
9812212
15.

Mechanisms of action of intravenous immunoglobulin in inflammatory muscle disease.

Quick A, Tandan R.

Curr Rheumatol Rep. 2011 Jun;13(3):192-8. doi: 10.1007/s11926-011-0171-0. Review.

PMID:
21503696
16.

Cellular aspects of myositis.

Mantegazza R, Bernasconi P.

Curr Opin Rheumatol. 1994 Nov;6(6):568-74. Review.

PMID:
7865375
17.

Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.

Sallum AM, Kiss MH, Silva CA, Wakamatsu A, Vianna MA, Sachetti S, Marie SK.

Autoimmun Rev. 2006 Feb;5(2):93-100. Review.

PMID:
16431335
18.

Inflammatory muscle diseases.

Mastaglia FL.

Neurol India. 2008 Jul-Sep;56(3):263-70. Review.

19.

Innate immune processes in lupus erythematosus.

Aringer M, G√ľnther C, Lee-Kirsch MA.

Clin Immunol. 2013 Jun;147(3):216-22. doi: 10.1016/j.clim.2012.11.012. Review.

PMID:
23290784
20.

Polymyositis and dermatomyositis: pathophysiology.

Nagaraju K, Lundberg IE.

Rheum Dis Clin North Am. 2011 May;37(2):159-71, v. doi: 10.1016/j.rdc.2011.01.002. Review.

PMID:
21444017
Items per page

Supplemental Content

Support Center